Page 251 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 251

PP-68



               SH003 reduces high-fat diet-induced myosteatosis through gut microbiota-

               associated effects


                                                               2
                                                                                               2
                                           2
                              #,1
                                                                             2
               Hye-Lin Kim,  Mina Boo,  Hyunyoung Choi,  Suhyeon An,  HyunSoo Yang,  Jae Heon
                                                       1,2
                                       1
                                                                          ,3
                    2
               Sim, Dong-Hyun Youn,  Jinbong Park,  Seong-Gyu Ko*

               1  Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul,
                 Republic of Korea
               2  Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul,
                 Republic of Korea
               3  Korean Medicine-Based Drug Repositioning Cancer Research Center, Seoul, Republic of
                 Korea
               * E-mail: epiko@khu.ac.kr

               Abstract
                  SH003, a standardized herbal formula composed of  Astragalus membranaceus, Angelica
               gigas,  and  Trichosanthes  kirilowii,  has  known  anti-cancer  and  anti-inflammatory  effects.
               However, its impact on skeletal muscle lipid metabolism (myosteatosis) and gut microbiota
               remains largely unexplored. The anti-adipogenic effects of SH003 were assessed in 3T3-L1
               adipocytes using Oil Red O staining. For in vivo studies, C57BL/6J mice were fed a high-fat
               diet (HFD) for 4 weeks to induce obesity, followed by 6 weeks of SH003 administration. Body
               weight, oral glucose tolerance (OGTT), and intramuscular lipid accumulation were evaluated.
               Gut microbiome composition  was  analyzed in  HFD and normal  diet mice with  or without
               SH003 treatment. SH003 treatment dose-dependently inhibited lipid accumulation in 3T3-L1
               cells and modulated serum-mediated adipogenic signals. In HFD-fed mice, SH003 reduced
               body weight gain, improved glucose tolerance, and significantly attenuated intramuscular lipid
               deposition, indicating alleviation of myosteatosis. Microbiome profiling revealed enrichment
               of short-chain fatty acid (SCFA)-producing taxa in SH003-treated mice, suggesting that gut
               microbiota modulation may contribute to systemic metabolic benefits. SH003 mitigates HFD-
               induced  metabolic  dysfunction  and  myosteatosis  by  reducing  adipogenesis  and  improving
               skeletal  muscle  lipid  metabolism. These  findings  highlight  a  potential  link  between  herbal
               intervention, gut microbiota composition, and muscle lipid homeostasis, providing a foundation
               for future research on dietary or herbal strategies targeting metabolic health.

               Keywords: SH003; Myosteatosis; Gut microbiome; Short-chain fatty acids; High-fat diet
   246   247   248   249   250   251   252   253   254   255   256